- Home
- TTOO vs ONCY Comparison
TTOO vs ONCY Comparison
Compare TTOO & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- ONCY
- Stock Information
- Founded
- TTOO 2006
- ONCY 1998
- Country
- TTOO United States
- ONCY Canada
- Employees
- TTOO N/A
- ONCY N/A
- Industry
- TTOO Medical/Dental Instruments
- ONCY Pharmaceuticals and Biotechnology
- Sector
- TTOO Health Care
- ONCY Health Care
- Exchange
- TTOO Nasdaq
- ONCY Nasdaq
- Market Cap
- TTOO 36.4M
- ONCY 103.8M
- IPO Year
- TTOO 2014
- ONCY 1999
- Fundamental
- Price
- TTOO $0.97
- ONCY $1.19
- Analyst Decision
- TTOO Hold
- ONCY Strong Buy
- Analyst Count
- TTOO 1
- ONCY 2
- Target Price
- TTOO $5.00
- ONCY $4.00
- AVG Volume (30 Days)
- TTOO 710.5K
- ONCY 903.7K
- Earning Date
- TTOO 11-13-2024
- ONCY 11-05-2024
- Dividend Yield
- TTOO N/A
- ONCY N/A
- EPS Growth
- TTOO N/A
- ONCY N/A
- EPS
- TTOO N/A
- ONCY N/A
- Revenue
- TTOO $7,164,000.00
- ONCY N/A
- Revenue This Year
- TTOO $50.31
- ONCY N/A
- Revenue Next Year
- TTOO $117.92
- ONCY N/A
- P/E Ratio
- TTOO N/A
- ONCY N/A
- Revenue Growth
- TTOO N/A
- ONCY N/A
- 52 Week Low
- TTOO $0.90
- ONCY $0.84
- 52 Week High
- TTOO $8.38
- ONCY $1.80
- Technical
- Relative Strength Index (RSI)
- TTOO 18.34
- ONCY 52.51
- Support Level
- TTOO $0.90
- ONCY $1.17
- Resistance Level
- TTOO $1.86
- ONCY $1.28
- Average True Range (ATR)
- TTOO 0.15
- ONCY 0.09
- MACD
- TTOO -0.00
- ONCY -0.01
- Stochastic Oscillator
- TTOO 5.72
- ONCY 28.00
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.